Edwards' transcatheter trilogy: an exclusive portfolio of three options to treat tricuspid regurgitation

Sponsored by Edwards Lifesciences

Anchorperson: J. Hausleiter

Moderator: F. Praz

Summary

In this session broadcast at PCR London Valves 2021, discuss and explore transcatheter therapies for the treatment of tricuspid regurgitation and their clinical impact, analyze the recorded live case of an 81-year-old female patient from Leipzig, and discover the potential of transcatheter replacement technologies in the future for the treatment of tricuspid regurgitation.

Learning Objectives

To explore the transcatheter therapies for TR treatment and their clinical impact
To participate in a recorded live case demonstration of edge-to-edge repair using the PASCAL platform
To discover the potential of transcatheter replacement technologies for the treatment of TR